Synergetics
Implementation drives our intense commitment to every project we undertake.
Synergetics AdvantageCase Histories Company
Capabilities
Industries
Strategic Partners

September 2008
Sarro named to Xantrex Technologies Inc., board
September 2008
Due Diligence Engagement
September 2008
Acquisition and Integration Assessment

Leading BioTech Company

Background

Since 1993 this leading BioTech company processes umbilical cords and acts as a stem cell blood banking center. Their role is to receive cord blood and expeditiously prepare and process the blood before cryogenically freezing it in temperatures in excess of -184 degrees Celsius. The timely processing of cord blood (or stem cells) is critical in order to maintain maximum viability (or cell count) prior to freezing and preserving the blood for potential future use in transplants or otherwise.

The parent company headquartered in Boston, Massachusetts is a cutting edge stem cell research firm with leading studies designed for cellular therapy. Their trademark is the process of “selective amplification” of the repopulating stem cells. Umbilical cord stem cells are today a part of therapy regimen for 50 diseases. The revenue-generating arm of the research firm is located in Hebron, Kentucky and has projected annual sales revenue of $27-30 million dollars. They employ approximately 35 people in Kentucky and process all patient cords from around the world at this facility.

After gaining approval from the FDA for stem cell (umbilical cord) blood banking procedure, this company needed to establish and improve their process modeled in large part like existing traditional blood banks. After doing so, the popularity of banking stem cells began to grow and so the challenge was to improve the existing process and prepare for the expected increase in interest and volume.

The Problem

Without internal resources and expertise this company commissioned Synergetics to help improve processes in both the preparation area and processing laboratory. This was mandatory to enable the expected 5% monthly growth and simultaneously reduce variable costs. Capital investment and plant expansion is inevitable however, management intuitively realized that there was plenty of opportunity to increase the utilization of current resources and optimize a relatively immature process.

Scope and Assignment

Synergetics was asked to look at operations including Prep/Setup, Processing (lab) and Freeze areas for quality, cycle time and productivity improvements throughout. The existing team of professionals were overwhelmed with the regulatory requirements; primarily manual documentation, and needed “rethink” the value added nature of all procedures. The project focused in the following areas:

  • Forecasting and Capacity Planning
  • LEAN Manufacturing Principles (Layouts, Processes & Systems)
  • Manufacturing Metrics and Management Training
  • Lab Software Assessment & Assistance
  • Overhead and Management Rationalization

The Results

  • Initial management reorganization has reduced overhead (labor) costs by 18% annually.
  • Productivity improved as much as 35%, to be realized in smaller increments relative to increased volume. Overall Unit Cost is down by 24%
  • Overhead/Management tasks reduced by a minimum of 10%, and refocused on more relative tasks
  • Management training is underway in every phase of the operation, and related corporate level training as well. (LEAN Manufacturing & System for Managing)
  • The continuous improvement approach has and will continue to improve both cell recoverability and cycle time from birth to freeze
  • Based on the partnership with Synergetics, this company is expected to realize a 6.5 to 1 ROI
  • By successfully increasing the capacity at the processing facility the natural progression took us to the Sales Call Center, our second area within the company, in order to apply methods and systems which will help increase enrollments.
Previous | Next
Index

 

Synergetics Installations Worldwide, Inc.